Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Artículo en Japonés | MEDLINE | ID: mdl-17879595

RESUMEN

Sandalwood oil is widely used in aromatherapy for alleviating various symptoms. Santalol, a major component of sandalwood oil, has been reported to have central nervous system depressant effects such as sedation. In the present study, we investigated the effect of santalol on the sleep-wake cycle in sleep-disturbed rats. When inhaled at a concentration of 5 X 10(-2) ppm, santalol caused a significant decrease in total waking time and an increase in total non-rapid eye movement (NREM) sleep time. In order to clarify the mechanism of action, olfactory hypofunction was caused in rats by intranasal application of 5% zinc sulfate solution, and thereafter the effects of inhalation of fragrances were evaluated. In this study, it was found that the impairment of the olfactory system showed no significant effect on the changes in sleep parameters induced by santalol. This result suggests that santalol may act via the circulatory system rather than the olfactory system. That is, santalol is thought to be absorbed into the blood through the respiratory mucosa, and then exert its action. From these results, it is concluded that santalol may be useful in patients having difficulty maintaining sleep without being affected by individual differences in perfume-related preference.


Asunto(s)
Aromaterapia , Sesquiterpenos/uso terapéutico , Trastornos del Sueño-Vigilia/terapia , Administración por Inhalación , Animales , Modelos Animales de Enfermedad , Masculino , Sesquiterpenos Policíclicos , Ratas , Ratas Wistar , Mucosa Respiratoria/metabolismo , Sesquiterpenos/administración & dosificación , Sesquiterpenos/farmacocinética , Sesquiterpenos/farmacología , Fases del Sueño/efectos de los fármacos , Olfato/fisiología
2.
Biol Pharm Bull ; 28(5): 808-10, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15863883

RESUMEN

In the present study, we investigated hypnotic activities of chamomile and passiflora extracts using sleep-disturbed model rats. A significant decrease in sleep latency was observed with chamomile extract at a dose of 300 mg/kg, while passiflora extract showed no effects on sleep latency even at a dose of 3000 mg/kg. No significant effects were observed with both herbal extracts on total times of wakefulness, non-rapid eye movement (non-REM) sleep and REM sleep. Flumazenil, a benzodiazepine receptor antagonist, at a dose of 3 mg/kg showed a significant antagonistic effect on the shortening in sleep latency induced by chamomile extract. No significant effects were observed with chamomile and passiflora extracts on delta activity during non-REM sleep. In conclusion, chamomile extract is a herb having benzodiazepine-like hypnotic activity.


Asunto(s)
Manzanilla , Hipnóticos y Sedantes/uso terapéutico , Passiflora , Trastornos del Sueño-Vigilia/tratamiento farmacológico , Animales , Relación Dosis-Respuesta a Droga , Electroencefalografía/efectos de los fármacos , Flores , Hipnóticos y Sedantes/aislamiento & purificación , Hipnóticos y Sedantes/farmacología , Masculino , Componentes Aéreos de las Plantas , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Ratas Wistar , Trastornos del Sueño-Vigilia/fisiopatología
3.
Psychopharmacology (Berl) ; 180(3): 564-9, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15700178

RESUMEN

RATIONALE: Kava-kava extract may be useful as an herbal medicine for treatment of insomnia and anxiety. OBJECTIVES: The present study was undertaken to investigate the effects of kava-kava extract on the sleep-wake cycle in comparison with that of flunitrazepam using sleep-disturbed rats. METHODS: Electrodes for measurement of electroencephalogram (EEG) and electromyogram (EMG) were implanted into the frontal cortex and the dorsal neck muscle of rats. EEG and EMG were recorded with an electroencephalogram. SleepSign ver.2.0 was used for EEG and EMG analysis. Total times of wakefulness, non-rapid eye movement (non-REM) and REM sleep were measured from 09:00 to 15:00. RESULTS: A significant shortening of the sleep latency in sleep-disturbed rats was observed following the administration of kava-kava extract at a dose of 300 mg/kg, while no effects were observed on the total waking and non-REM sleep time. On the other hand, flunitrazepam showed a significant shortening in sleep latency, decrease in total waking time and increase in total non-REM sleep time. Although the effects of flunitrazepam were antagonized by the benzodiazepine receptor antagonist flumazenil, the effect of kava-kava extract was not antagonized by flumazenil. Kava-kava extract showed a significant increase in delta activity during non-REM sleep in sleep-disturbed rats, whereas a significant decrease in delta power during non-REM sleep was observed with flunitrazepam. Flumazenil caused no significant effect on the changes in delta activity induced by both kava-kava extract and flunitrazepam. CONCLUSIONS: Kava-kava extract is an herbal medicine having not only hypnotic effects, but also sleep quality-enhancement effects.


Asunto(s)
Kava/química , Extractos Vegetales/farmacología , Trastornos del Inicio y del Mantenimiento del Sueño/tratamiento farmacológico , Animales , Ritmo Delta , Relación Dosis-Respuesta a Droga , Electromiografía , Flumazenil/farmacología , Flunitrazepam/farmacología , Moduladores del GABA/farmacología , Masculino , Fitoterapia , Extractos Vegetales/química , Ratas , Ratas Wistar , Sueño REM/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA